Ensayos clínicos

8.676 ensayos encontrados

CompletadoRENIS

PTC124-GD-021e-CF: ESTUDIO DE EXTENSIÓN DE FASE 3 DE ATALUREN (PTC124) EN PACIENTES CON FIBROSIS QUÍSTICA POR MUTACIÓN SIN SENTIDO

INTERVENTIONALID: IS001194

CompletadoRENIS

EFC13579- LIBERTY ASTHMA QUEST- Evaluación de Dupilumab en Pacientes con asma persistente

INTERVENTIONALID: IS001165

CompletadoRENIS

Estudio triple para asma alta concentración con ICS/LABA hs y tiotropio (estudio TRIGGER) (TRIple in asthma hiGh strenGth vErsus ICS/LABA hs and tiotRopium)

INTERVENTIONALID: IS000973

CompletadoRENIS

PTC124-GD-021-CF: Un estudio fase 3 de eficacia y seguridad de Ataluren (PTC124®) en pacientes con fibrosis quística por mutación sin sentido.

INTERVENTIONALID: IS000818

CompletadoRENIS

Ciprofloxacina en polvo seco para inhalación en las bronquiectasias no debidas a fibrosis quística (BE-no-FQ)

INTERVENTIONALID: IS000670

CompletadoRENIS

Ciprofloxacina en polvo seco para inhalación en las bronquiectasias no debidas a fibrosis quística (BE-no-FQ)

INTERVENTIONALID: IS000466

CompletadoFase 2ClinicalTrials.gov

A Phase 2b, Parallel Group, Placebo And Active Comparator Controlled Study To Investigate The Safety, Toleration And Efficacy Of 6-Week Once Daily Administration Of Inhaled PF-00610355 Dry Powder In Patients With Moderate Chronic Obstructive Pulmonary Disease.

INTERVENTIONALInicio: 1 de mar de 2010ID: NCT00808288

TerminadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age

INTERVENTIONALInicio: 20 de nov de 2020ID: NCT04605159

Activo, no reclutaFase 2ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Participants With Noncirrhotic Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis

INTERVENTIONALInicio: 14 de nov de 2022ID: NCT05327127

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab in Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations (MIRANDA)

INTERVENTIONALInicio: 22 de sept de 2023ID: NCT06040086

Activo, no reclutaFase 2ClinicalTrials.gov

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

INTERVENTIONALInicio: 27 de feb de 2024ID: NCT06196879

TerminadoFase 3ClinicalTrials.gov

Phase III, Randomized, Observer-blind, Placebo-controlled, Multi-center, Multinational Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PEARL)

INTERVENTIONALInicio: 6 de feb de 2024ID: NCT06252285

CompletadoFase 3ClinicalTrials.gov

An Open-label Trial of the Long-term Safety and Tolerability of Nintedanib Per os, on Top of Standard of Care, Over at Least 3 Years, in Children and Adolescents With Clinically Significant Fibrosing Interstitial Lung Disease (InPedILD®-ON)

INTERVENTIONALInicio: 6 de abr de 2022ID: NCT05285982

CompletadoFase 3ClinicalTrials.gov

A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

INTERVENTIONALInicio: 16 de nov de 2022ID: NCT05321082

CompletadoFase 3ClinicalTrials.gov

Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

INTERVENTIONALInicio: 16 de dic de 2020ID: NCT04701983

Activo, no reclutaFase 2ClinicalTrials.gov

A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR or HER2 Mutation

INTERVENTIONALInicio: 9 de jul de 2019ID: NCT03974022

CompletadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

INTERVENTIONALInicio: 31 de jul de 2013ID: NCT01868061

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation

INTERVENTIONALInicio: 6 de jul de 2020ID: NCT04456673

Activo, no reclutaClinicalTrials.gov

Effect of High-Flow Tracheal Oxygen on End-Expiratory Lung Impedance in Tracheostomized Patients

INTERVENTIONALInicio: 1 de dic de 2024ID: NCT06824220

CompletadoClinicalTrials.gov

Impact of High Flow Oxygen Therapy on Diaphragm Thickening Fraction in Healthy Subjects. A Prospective Cohort Study

INTERVENTIONALInicio: 1 de mar de 2022ID: NCT06086769